CN Patent

CN109776637B — 核苷氨基磷酸酯前药

Assigned to Gilead Sciences Inc · Expires 2023-04-18 · 3y expired

What this patent protects

本文公开了用于治疗哺乳动物病毒性感染的核苷氨基磷酸酯前药化合物或其立体异构体，以及包含其的组合物及其制备方法。

USPTO Abstract

本文公开了用于治疗哺乳动物病毒性感染的核苷氨基磷酸酯前药化合物或其立体异构体，以及包含其的组合物及其制备方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN109776637B
Jurisdiction: CN
Classification: —
Expires: 2023-04-18
Drug substance claim: No
Drug product claim: No
Assignee: Gilead Sciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.